# Novartis Pharma Stein AG - Inspection Records Source: https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b > Inspection records and compliance data for Novartis Pharma Stein AG in Stein Ag, None. Access full analysis and detailed observations. --- ## Details - Name: Novartis Pharma Stein AG - FEI Number: 3002653483 - City: Stein Ag - State: None - Country Name: Switzerland - Address Line 1: Schaffhauserstrasse 101 - Zip Code: None - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [483 - Novartis Pharma Stein AG - 2026-05-19](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/7256aae6-5bf4-4371-ab4d-8a6f90ee21a6) — source: FDA, date: May 19, 2026 - [FDA Inspection 1230809 - Novartis Pharma Stein AG - 2023-11-20](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/161d111e-4fc5-4071-9a22-adb475a24dd0) — source: FDA, date: November 20, 2023 - [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/50585e29-a34c-4320-aca5-c3193ba50374) — source: FDA, date: December 6, 2022 - [483 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/e63a23c8-caec-4d2b-9ed3-27a499bfdb25) — source: FDA, date: December 6, 2022 - [FDA Inspection 1192104 - Novartis Pharma Stein AG - 2022-12-06](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/5994d6f5-291c-4a32-87bf-4376f992a6bb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2022 - [483 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/3e713a20-3bd1-4991-aad5-bac1eccc2725) — source: FDA, date: December 4, 2018 - [FDA Inspection 1073408 - Novartis Pharma Stein AG - 2018-12-04](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3f2284e9-7b71-4b40-a3f0-ac4686b89e80) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 4, 2018 - [483 - Novartis Pharma Stein AG - 2018-09-21](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/7b770256-872c-467d-b840-a8336bd5c659) — source: FDA, date: September 21, 2018 - [483 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/483/novartis-pharma-stein-ag/744bc0b9-9ae9-4b95-8ef6-c6abe8b8f1c6) — source: FDA, date: May 9, 2017 - [FDA Inspection 1015468 - Novartis Pharma Stein AG - 2017-05-09](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/41e9858b-8978-450a-9e2b-657833e31ff4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 9, 2017 - [FDA Inspection 947993 - Novartis Pharma Stein AG - 2015-10-16](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6aecea73-0741-4c95-b1cf-6aedfc498659) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 16, 2015 - [FDA Inspection 924507 - Novartis Pharma Stein AG - 2015-05-01](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/c4877126-7aef-4183-bd25-589a52fba74d) — classification: No Action Indicated (NAI), source: FDA, date: May 1, 2015 - [FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/6894d4cd-3775-4701-bfbb-ced0311aec69) — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014 - [FDA Inspection 875305 - Novartis Pharma Stein AG - 2014-03-25](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/3304c33b-5488-4124-9d1d-9e645a816ed5) — classification: No Action Indicated (NAI), source: FDA, date: March 25, 2014 - [FDA Inspection 791807 - Novartis Pharma Stein AG - 2012-06-22](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/8ac5186e-490b-4203-92f2-5088421c6033) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 22, 2012 - [FDA Inspection 672681 - Novartis Pharma Stein AG - 2010-07-02](https://www.keypedia.com/records/fda_inspections/novartis-pharma-stein-ag/05f49b75-8ef7-4a5d-89fb-ba4f8a35901e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 2, 2010 ## Related Companies - [Amgen Manufacturing Ltd](https://www.keypedia.com/companies/amgen-manufacturing-ltd/cecb788c-4cd6-4c26-9331-7b68b4f12369) - [Biological E. Limited](https://www.keypedia.com/companies/biological-e-limited/a02640a2-3dc0-448e-9a4f-df7e189939e4) - [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1) - [Daewoong Pharmaceutical Co. Ltd. (Hyangnam factory)](https://www.keypedia.com/companies/daewoong-pharmaceutical-co-ltd-hyangnam-factory/2f9e6a6a-9f69-4377-b1ef-5500338ce477) - [Pharmaron Shaoxing Co., Ltd](https://www.keypedia.com/companies/pharmaron-shaoxing-co-ltd/46e46053-2a60-4ce8-9f9f-b4fe235c95f9) - [Shanghai Henlius Biopharmaceuticals Co., Ltd.](https://www.keypedia.com/companies/shanghai-henlius-biopharmaceuticals-co-ltd/27f2ead3-2366-4479-aa2e-d9895581080b) - [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362) - [ALK-Abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/b626f86d-b379-45aa-96d2-0661e9d1c981) - [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9) - [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b) ## Related Officers - [investigator](https://www.keypedia.com/people/don-h-bark/c91b02bc-f735-46d8-a0ef-b44724868908) - [Ademola O. Daramola](https://www.keypedia.com/people/ademola-o-daramola/814113a4-38bc-4ce5-b6af-09c7e688c0ec) - [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942) - [Anjali Shukla](https://www.keypedia.com/people/anjali-shukla/23e50484-91bf-436f-971e-2efd3c2b3d0a) - [Travis S. Bradley](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8) - [CSO](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)